drugset / Trial / NCT02961478

Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure

NCT02961478

Phase 3 Completed 150 enrolled University Hospital, Angers
NaSingle-groupOpen-labelDiagnostic

Summary

IOXSOR study's purpose to determine the frequency of non resolutive renal failure (estimated by the clearance of iohexol) at end of stay in ICU patients who have had acute renal failure episode.

Timeline

Start
2017-02-10
Primary completion
2022-11-11
Completion
2022-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Iohexol Diagnostic / imaging agent

Indications